New on the MedlinePlus Porphyria page:
04/13/2016 02:39 PM EDT
Source: National Library of Medicine -
porphyria
Porphyria is a group of disorders caused by abnormalities in the chemical steps that lead to heme production. Heme is a vital molecule for all of the body's organs, although it is most abundant in the blood, bone marrow, and liver. Heme is a component of several iron-containing proteins called hemoproteins, including hemoglobin (the protein that carries oxygen in the blood).
Researchers have identified several types of porphyria, which are distinguished by their genetic cause and their signs and symptoms. Some types of porphyria, called cutaneous porphyrias, primarily affect the skin. Areas of skin exposed to the sun become fragile and blistered, which can lead to infection, scarring, changes in skin coloring (pigmentation), and increased hair growth. Cutaneous porphyrias include congenital erythropoietic porphyria, erythropoietic protoporphyria, hepatoerythropoietic porphyria, and porphyria cutanea tarda.
Other types of porphyria, called acute porphyrias, primarily affect the nervous system. These disorders are described as "acute" because their signs and symptoms appear quickly and usually last a short time. Episodes of acute porphyria can cause abdominal pain, vomiting, constipation, and diarrhea. During an episode, a person may also experience muscle weakness, seizures, fever, and mental changes such as anxiety and hallucinations. These signs and symptoms can be life-threatening, especially if the muscles that control breathing become paralyzed. Acute porphyrias include acute intermittent porphyria and ALAD deficiency porphyria. Two other forms of porphyria, hereditary coproporphyria and variegate porphyria, can have both acute and cutaneous symptoms.
The porphyrias can also be split into erythropoietic and hepatic types, depending on where damaging compounds called porphyrins and porphyrin precursors first build up in the body. In erythropoietic porphyrias, these compounds originate in the bone marrow. Erythropoietic porphyrias include erythropoietic protoporphyria and congenital erythropoietic porphyria. Health problems associated with erythropoietic porphyrias include a low number of red blood cells (anemia) and enlargement of the spleen (splenomegaly). The other types of porphyrias are considered hepatic porphyrias. In these disorders, porphyrins and porphyrin precursors originate primarily in the liver, leading to abnormal liver function and an increased risk of developing liver cancer.
Environmental factors can strongly influence the occurrence and severity of signs and symptoms of porphyria. Alcohol, smoking, certain drugs, hormones, other illnesses, stress, and dieting or periods without food (fasting) can all trigger the signs and symptoms of some forms of the disorder. Additionally, exposure to sunlight worsens the skin damage in people with cutaneous porphyrias.
MEDICAL ENCYCLOPEDIA
National Institutes of Health
Porphyrias are a group of genetic disorders caused by problems with how your body makes a substance called heme. Heme is found throughout the body, especially in your blood and bone marrow, where it carries oxygen.
There are two main types of porphyrias. One affects the skin and the other affects the nervous system. People with the skin type develop blisters, itching, and swelling of their skin when it is exposed to sunlight. The nervous system type is called acute porphyria. Symptoms include pain in the chest, abdomen, limbs, or back; muscle numbness, tingling, paralysis, or cramping; vomiting; constipation; and personality changes or mental disorders. These symptoms come and go.
Certain triggers can cause an attack, including some medicines, smoking, drinking alcohol, infections, stress, and sun exposure. Attacks develop over hours or days. They can last for days or weeks.
Porphyria can be hard to diagnose. It requires blood, urine, and stool tests. Each type of porphyria is treated differently. Treatment may involve avoiding triggers, receiving heme through a vein, taking medicines to relieve symptoms, or having blood drawn to reduce iron in the body. People who have severe attacks may need to be hospitalized.
NIH: National Institute of Diabetes and Digestive and Kidney Diseases
- First-Line Tests (American Porphyria Foundation)
- Porphyrin Tests (American Association for Clinical Chemistry)
- Porphyrins and Porphyria Diagnosis (American Porphyria Foundation)
- Porphyria Treatment Options (American Porphyria Foundation)
- Diet and Nutrition in Porphyria (American Porphyria Foundation)
- Glucose Effect in the Acute Porphyrias (American Porphyria Foundation)
- Porphyria Cutanea Tarda and Agent Orange (Department of Veterans Affairs)
- Weight Loss & Acute Porphyria (American Porphyria Foundation)
- Acute Intermittent Porphyria (AIP) (American Porphyria Foundation)
- Congenital Erythropoietic Porphyria (CEP) (American Porphyria Foundation)
- Erythropoietic Protoporphyria (EPP) or Protoporphyria (American Porphyria Foundation)
- Porphyria Cutanea Tarda (American Osteopathic College of Dermatology)
- Porphyria Cutanea Tarda (PCT) (American Porphyria Foundation)
- Genetics Home Reference: dyserythropoietic anemia and thrombocytopenia (National Library of Medicine)
- Genetics Home Reference: porphyria (National Library of Medicine)
- Learning about Porphyria (National Human Genome Research Institute)
- ClinicalTrials.gov: Porphyrias (National Institutes of Health)
- Delta-ALA urine test Available in Spanish
- PBG urine test Available in Spanish
- Porphyria Available in Spanish
- Porphyria (National Institute of Diabetes and Digestive and Kidney Diseases)
- Porphyrins - blood test Available in Spanish
- Porphyrins - urine Available in Spanish
No hay comentarios:
Publicar un comentario